We are very proud to announce our new British Innovation Fund II, targeting “high-impact, early stage companies” with links to the UK’s university sector, as published in City AM this morning.
The fund will follow on from our first British Innovation Fund, which also invested in the spin-out companies from the university sector. The new fund, however, will “go further in actively supporting promising start-ups with cutting-edge IP capable of disrupting a range of industries”, with a focus on global food systems and health.
Milltrust CEO Simon Hopkins said the fund “represents a significant step forward in our strategy to foster Sustainable Prosperity across the globe, recognising the outsized positive impact that rapidly-growing, IP-rich companies can have”.
Previous investments from the British Innovation Fund include Roslin Technologies, a “cutting-edge biotech company” in the cultivated meat industry, and Vaccitech, a vaccine developer at the University of Oxford’s Jenner Institute.